Ferriprotoporphyrin IX (Heme) (FP-IX)

Ferriprotoporphyrin IX, commonly referred to as heme, is a central metabolic byproduct and therapeutic target within the digestive vacuole of Plasmodium species, the causative agents of malaria (Hempelmann, 2007; Sullivan, 2002). During the parasite's intraerythrocytic stage, it ingests and degrades host hemoglobin to acquire amino acids, a process that releases free, toxic ferriprotoporphyrin IX (Egan, 2008). Because free heme can generate reactive oxygen species and damage lipid membranes, the parasite has evolved a unique detoxification mechanism to convert it into chemically inert, crystalline hemozoin (PubChem CID 445639). Many classic antimalarial agents, such as chloroquine and quinine, exert their parasiticidal effects by binding to ferriprotoporphyrin IX or the growing faces of hemozoin crystals (StatPearls, 2023). This interference prevents further detoxification, causing an accumulation of toxic heme-drug complexes that disrupt vacuolar function and lead to parasite death.

Other names

HemeFerrihemeHematinFP-IXProtoporphyrin IX iron(III) complex

Inhibition of hemozoin formation (biocrystallization) by binding to ferriprotoporphyrin IX, leading to the accumulation of toxic free heme and heme-drug complexes that cause oxidative damage and membrane lysis within the parasite digestive vacuole (Egan, 2008; Hempelmann, 2007).